Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Current Assets (2016 - 2025)

iBio (IBIO) has disclosed Current Assets for 15 consecutive years, with $53.4 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 542.99% to $53.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.4 million through Dec 2025, up 542.99% year-over-year, with the annual reading at $9.7 million for FY2025, 37.97% down from the prior year.
  • Current Assets for Q4 2025 was $53.4 million at iBio, up from $50.8 million in the prior quarter.
  • The five-year high for Current Assets was $107.2 million in Q1 2021, with the low at $6.1 million in Q1 2025.
  • Average Current Assets over 5 years is $43.2 million, with a median of $37.2 million recorded in 2022.
  • The sharpest move saw Current Assets soared 940.4% in 2021, then crashed 83.12% in 2025.
  • Over 5 years, Current Assets stood at $67.5 million in 2021, then tumbled by 43.35% to $38.2 million in 2022, then crashed by 48.48% to $19.7 million in 2023, then tumbled by 57.87% to $8.3 million in 2024, then skyrocketed by 542.99% to $53.4 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $53.4 million, $50.8 million, and $9.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.